Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Talniflumate with Neoadjuvant Chemotherapy in Breast Cancer
NCT06777537Phase 4Not yet recruiting
- Sponsor
- Shandong University
- Start
- Jun 2025
- Primary completion
- Dec 2030
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of talniflumate in breast cancer, sponsored by Shandong University. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
talniflumate
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT06777537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06777537.